{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:42:38Z","timestamp":1772908958226,"version":"3.50.1"},"reference-count":41,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/ijo.2016.3416","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T08:00:42Z","timestamp":1457078442000},"page":"2098-2112","source":"Crossref","is-referenced-by-count":40,"title":["Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway"],"prefix":"10.3892","volume":"48","author":[{"given":"TAO","family":"XIE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAI-YONG","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAI-QING","family":"LIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIN-PING","family":"MAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TING","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHENG-DONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHAO-MING","family":"YE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"key20180107185321_b1-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijoa.2010.03.013","article-title":"Management of a parturient with high-grade osteosarcoma of the proximal femur: A multidisciplinary approach","volume":"19","author":"Quaye","year":"2010","journal-title":"Int J Obstet Anesth"},{"key":"key20180107185321_b2-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4419-0284-9_4","article-title":"Osteosarcoma multidisciplinary approach to the management from the pathologist's perspective","volume":"152","author":"Raymond","year":"2009","journal-title":"Cancer Treat Res"},{"key":"key20180107185321_b3-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11912-014-0395-z","article-title":"Advances in therapy for pediatric sarcomas","volume":"16","author":"Weiss","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"key20180107185321_b4-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1179\/1973947812Y.0000000055","article-title":"Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: A phase II trial in Japan","volume":"25","author":"Kudawara","year":"2013","journal-title":"J Chemother"},{"key":"key20180107185321_b5-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107185321_b6-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1200\/JCO.2005.04.063","article-title":"Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)","volume":"23","author":"Kempf-Bielack","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107185321_b7-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/10454411930040020401","article-title":"Matrix metalloproteinases: A review","volume":"4","author":"Birkedal-Hansen","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"key":"key20180107185321_b8-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.2006.01972.x","article-title":"Emmprin (basigin\/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression","volume":"56","author":"Nabeshima","year":"2006","journal-title":"Pathol Int"},{"key":"key20180107185321_b9-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1684\/bdc.2011.1398","article-title":"The role of RANK\/RANKL\/osteoprotegerin (OPG) triad in cancer-induced bone diseases: Physiopathology and clinical implications","volume":"98","author":"Cl\u00e9zardin","year":"2011","journal-title":"Bull Cancer"},{"key":"key20180107185321_b10-ijo-48-05-2098","first-page":"1","article-title":"Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum","volume":"30","author":"Yamasaki","year":"1976","journal-title":"Acta Med Okayama"},{"key":"key20180107185321_b11-ijo-48-05-2098","first-page":"1256","article-title":"Activation of PI3K\/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis","volume":"5","author":"Zhou","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20180107185321_b12-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.lfs.2006.02.014","article-title":"Effect of sinomenine on gene expression of the IL-1 beta-activated human synovial sarcoma","volume":"79","author":"Li","year":"2006","journal-title":"Life Sci"},{"key":"key20180107185321_b13-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3892\/ijo.2012.1704","article-title":"Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: Involvement of cell cycle arrest and apoptosis induction","volume":"42","author":"Lu","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107185321_b14-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3892\/ol.2011.305","article-title":"Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression","volume":"2","author":"Lv","year":"2011","journal-title":"Oncol Lett"},{"key":"key20180107185321_b15-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"e1356","DOI":"10.1038\/cddis.2014.321","article-title":"MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: An in vitro and in vivo study","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"key20180107185321_b16-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/aps.2009.21","article-title":"Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147","volume":"30","author":"Ou","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107185321_b17-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbrc.2015.07.004","article-title":"Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-\u03baB activation mediated by IL-4\/ miR-324-5p\/CUEDC2 axis","volume":"464","author":"Song","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107185321_b18-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.suronc.2009.09.002","article-title":"VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma","volume":"20","author":"Zhou","year":"2011","journal-title":"Surg Oncol"},{"key":"key20180107185321_b19-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jfo.2015.09.006","article-title":"Current treatments for corneal neovascularization","volume":"38","author":"Benayoun","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"key20180107185321_b20-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1160\/TH04-08-0536","article-title":"Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression","volume":"93","author":"Yan","year":"2005","journal-title":"Thromb Haemost"},{"key":"key20180107185321_b21-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2005.06.031","article-title":"Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and\/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate","volume":"23","author":"Meyers","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107185321_b22-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jep.2011.05.048","article-title":"Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-\u03b1-activated human fibroblast-like synoviocytes in rheumatoid arthritis","volume":"137","author":"Chen","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"key20180107185321_b23-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-4-23","article-title":"Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase","volume":"4","author":"Qian","year":"2007","journal-title":"J Neuroinflammation"},{"key":"key20180107185321_b24-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14786410600921417","article-title":"Synthesis and anti-inflammatory activities investigation of sinomenine derivatives on ring C","volume":"20","author":"Tang","year":"2006","journal-title":"Nat Prod Res"},{"key":"key20180107185321_b25-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"e98560","DOI":"10.1371\/journal.pone.0098560","article-title":"Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185321_b26-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3892\/ol.2013.1592","article-title":"Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivo","volume":"6","author":"Liao","year":"2013","journal-title":"Oncol Lett"},{"key":"key20180107185321_b27-ijo-48-05-2098","first-page":"48","article-title":"Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners","volume":"69","author":"Chen","year":"2014","journal-title":"Pharmazie"},{"key":"key20180107185321_b28-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.7314\/APJCP.2014.15.16.6737","article-title":"Suppressive effect of sinomenine combined with 5-fluorouracil on colon carcinoma cell growth","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107185321_b29-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"8888","DOI":"10.1038\/srep08888","article-title":"Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"key20180107185321_b30-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"e74274","DOI":"10.1371\/journal.pone.0074274","article-title":"Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20180107185321_b31-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/cncr.22706","article-title":"Manipulating the chemokine-chemokine receptor network to treat cancer","volume":"109","author":"Ruffini","year":"2007","journal-title":"Cancer"},{"key":"key20180107185321_b32-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/bjc.2015.338","article-title":"HIF2\u03b1 is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma","volume":"113","author":"Micucci","year":"2015","journal-title":"Br J Cancer"},{"key":"key20180107185321_b33-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apjtm.2015.07.027","article-title":"Effect of CXCR4 pretreated with ultrasound-exposed microbubbles on accelerating homing of bone marrow mesenchymal stem cells to ischemic myocardium in AMI rats","volume":"8","author":"Gu","year":"2015","journal-title":"Asian Pac J Trop Med"},{"key":"key20180107185321_b34-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.ejca.2015.08.020","article-title":"CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients","volume":"51","author":"Sand","year":"2015","journal-title":"Eur J Cancer"},{"key":"key20180107185321_b35-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3892\/or.2015.4297","article-title":"A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment","volume":"34","author":"Han","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107185321_b36-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3892\/or.2014.3536","article-title":"Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107185321_b37-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s13277-013-0725-z","article-title":"CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer","volume":"34","author":"Shen","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180107185321_b38-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-011-0749-z","article-title":"RANKL\/RANK - beyond bones","volume":"89","author":"Hanada","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"key20180107185321_b39-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2741\/4187","article-title":"The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma","volume":"18","author":"Li","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20180107185321_b40-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1939-1676.2007.tb03022.x","article-title":"Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: A randomized, double-blind, placebo-controlled study","volume":"21","author":"Moore","year":"2007","journal-title":"J Vet Intern Med"},{"key":"key20180107185321_b41-ijo-48-05-2098","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12032-013-0624-6","article-title":"Prognostic factors for teenage and adult patients with high-grade osteosarcoma: An analysis of 240 patients","volume":"30","author":"Durnali","year":"2013","journal-title":"Med Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3416\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T06:55:53Z","timestamp":1567666553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,4]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/ijo.2016.3416"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3416","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}